News and Updates

$2.4 Million Dollars Awarded for MS Research Using Bone Marrow Stem Cells

A $2.4-million grant was awarded to two Ottawa researchers for their work in fighting the chronic and often disabling disease of the brain and spinal cord that is multiple sclerosis.

Dr. Harry Atkins and Dr. Mark Freedman will continue a closely watched clinical trial involving an experimental bone marrow stem cell transplant therapy. Their team was awarded the money by The Multiple Sclerosis Society of Canada.

Read More »

Take the first step towards the healthier life you deserve.

The Stem Cell Institute has integrated Intranasal MTF Therapy into its autism protocol:

  • MTF therapy features exosomes and over 300 beneficial molecules
  • Works in synergy with our stem cells
  • Offers anti-inflammatory and regenerative effects
  • Delivered in an easy-to-administer aerosol format via the nose
  • To discover more about MTF and its benefits, click here